India’s pharma industry showcases innovation, global ambitions at CPHI & PMEC India 2025
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
Surgical site infections and antimicrobial resistance remain major challenges globally
The company will soon be launching a new portfolio of products in this segment
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
The formulation is backed by over 80 clinical trials and 200 scientific publications
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
India presents one of the world’s largest untapped opportunities for neurovascular screening
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Subscribe To Our Newsletter & Stay Updated